Viewing StudyNCT04787289



Ignite Creation Date: 2024-05-06 @ 3:52 PM
Last Modification Date: 2024-10-26 @ 1:58 PM
Study NCT ID: NCT04787289
Status: RECRUITING
Last Update Posted: 2023-07-27
First Post: 2021-03-01

Brief Title: A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer
Sponsor:
Organization: British Columbia Cancer Agency